Michael Friedrich

771 total citations
16 papers, 565 citations indexed

About

Michael Friedrich is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Michael Friedrich has authored 16 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Michael Friedrich's work include MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (4 papers) and Immunotherapy and Immune Responses (3 papers). Michael Friedrich is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (4 papers) and Immunotherapy and Immune Responses (3 papers). Michael Friedrich collaborates with scholars based in Germany, Switzerland and Austria. Michael Friedrich's co-authors include Barbara Seliger, André Steven, Jan Budczies, Carsten Denkert, Paul Jank, Hans‐Martin Jäck, Mir‐Farzin Mashreghi, Andreas Radbruch, Katharina Pracht and R Axt-Fliedner and has published in prestigious journals such as Scientific Reports, Methods in enzymology on CD-ROM/Methods in enzymology and Cellular and Molecular Life Sciences.

In The Last Decade

Michael Friedrich

16 papers receiving 553 citations

Peers

Michael Friedrich
Jian Kang China
Alejandro Morales United States
Gabrielle Carvalho France
Sascha Hasan United States
Yang Brooks United States
Walbert J. Bakker Netherlands
Yale Liu China
Veronika Lang Germany
Gülden Dınız Türkiye
Chun Guo China
Jian Kang China
Michael Friedrich
Citations per year, relative to Michael Friedrich Michael Friedrich (= 1×) peers Jian Kang

Countries citing papers authored by Michael Friedrich

Since Specialization
Citations

This map shows the geographic impact of Michael Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Friedrich more than expected).

Fields of papers citing papers by Michael Friedrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Friedrich. The network helps show where Michael Friedrich may publish in the future.

Co-authorship network of co-authors of Michael Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Friedrich. A scholar is included among the top collaborators of Michael Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Friedrich. Michael Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vaxevanis, Christoforos, Marcus Bauer, Michael Friedrich, et al.. (2022). Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. OncoImmunology. 12(1). 2152998–2152998. 7 indexed citations
2.
Vaxevanis, Christoforos, Michael Friedrich, Sandy Tretbar, et al.. (2022). Identification and characterization of novel CD274 (PD‐L1) regulating microRNAs and their functional relevance in melanoma. Clinical and Translational Medicine. 12(7). e934–e934. 6 indexed citations
3.
Friedrich, Michael, Robert Stoehr, André Steven, et al.. (2020). CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma. Scientific Reports. 10(1). 6499–6499. 23 indexed citations
4.
Steven, André, Michael Friedrich, Paul Jank, et al.. (2020). What turns CREB on? And off? And why does it matter?. Cellular and Molecular Life Sciences. 77(20). 4049–4067. 129 indexed citations
5.
Friedrich, Michael, Robert Stoehr, Simon Jasinski‐Bergner, et al.. (2020). Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. Journal of Translational Medicine. 18(1). 371–371. 12 indexed citations
6.
Massa, Chiara, Michael Friedrich, Diana Handke, et al.. (2020). Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients. OncoImmunology. 9(1). 1774323–1774323. 29 indexed citations
7.
Friedrich, Michael, et al.. (2020). Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744. Journal for ImmunoTherapy of Cancer. 8(1). e000396–e000396. 25 indexed citations
8.
Massa, Chiara, Diana Handke, Anja Müeller, et al.. (2020). Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma. Journal of Clinical Medicine. 9(9). 2690–2690. 22 indexed citations
9.
Jasinski‐Bergner, Simon, et al.. (2019). An altered miTRAP method for miRNA affinity purification with its pros and cons. Methods in enzymology on CD-ROM/Methods in enzymology. 636. 323–337. 3 indexed citations
10.
Friedrich, Michael, Simon Jasinski‐Bergner, Chiara Massa, et al.. (2019). Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunology Immunotherapy. 68(10). 1689–1700. 62 indexed citations
11.
Tretbar, Sandy, et al.. (2019). Identification of Immune Modulatory miRNAs by miRNA Enrichment via RNA Affinity Purification. Methods in molecular biology. 1913. 81–101. 6 indexed citations
12.
Tretbar, Sandy, Anja Müller, Michael Friedrich, et al.. (2019). TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma. Oncotarget. 10(15). 1507–1524. 23 indexed citations
13.
Friedrich, Michael, Katharina Pracht, Mir‐Farzin Mashreghi, et al.. (2017). The role of the miR‐148/‐152 family in physiology and disease. European Journal of Immunology. 47(12). 2026–2038. 94 indexed citations
14.
Georg, Thomas, et al.. (2011). Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer.. PubMed. 32(6). 628–35. 10 indexed citations
15.
Georg, Thomas, et al.. (2010). Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer.. PubMed. 30(7). 2837–43. 22 indexed citations
16.
Diesing, D., et al.. (2003). Granulomatous mastitis. Archives of Gynecology and Obstetrics. 269(4). 233–6. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Kang Breakdown of academic impact, for papers by Alejandro Morales Breakdown of academic impact, for papers by Gabrielle Carvalho Breakdown of academic impact, for papers by Sascha Hasan Breakdown of academic impact, for papers by Yang Brooks Breakdown of academic impact, for papers by Walbert J. Bakker Breakdown of academic impact, for papers by Yale Liu Breakdown of academic impact, for papers by Veronika Lang Breakdown of academic impact, for papers by Gülden Dınız Breakdown of academic impact, for papers by Chun Guo
Rankless by CCL
2026